LBRX
LB Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.86 / 10
Underperform
LBRX's fundamentals are underwhelming, earning a 2.9/10 score. Key weaknesses include a high Days sales outstanding (72.55) and suboptimal PB-ROE dispersion, while moderate YoY revenue growth (78.47%) and a reasonable interest-coverage ratio (15.48) offer limited relief. Asset and cash metrics are also below peers, reinforcing a constrained outlook. The stock's low fundamental score and negative Asset-MV factor (-0.50) highlight ongoing operational challenges that investors must monitor.
Analysis Checks(8/10)
Revenue-MV
Value-0.26
Score3/3
Weight19.77%
1M Return10.54%
Value-0.26
Score3/3
Weight19.77%
1M Return10.54%
Days sales outstanding
Value72.55
Score2/3
Weight1.72%
1M Return1.10%
Value72.55
Score2/3
Weight1.72%
1M Return1.10%
Net income-Revenue
Value-0.17
Score2/3
Weight15.78%
1M Return8.45%
Value-0.17
Score2/3
Weight15.78%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight11.53%
1M Return6.68%
Value-0.50
Score1/3
Weight11.53%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.69%
1M Return1.11%
Value78.47
Score2/3
Weight1.69%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight15.76%
1M Return8.45%
Value0.46
Score2/3
Weight15.76%
1M Return8.45%
PB-ROE
Value0.06
Score1/3
Weight19.19%
1M Return9.57%
Value0.06
Score1/3
Weight19.19%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.65%
1M Return0.43%
Value92.66
Score2/3
Weight0.65%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight15.49%
1M Return8.41%
Value-0.07
Score2/3
Weight15.49%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight19.77%
1M Return10.54%
Value-0.26
Score3/3
Weight19.77%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.69%
1M Return1.11%
Value78.47
Score2/3
Weight1.69%
1M Return1.11%
Days sales outstanding
Value72.55
Score2/3
Weight1.72%
1M Return1.10%
Value72.55
Score2/3
Weight1.72%
1M Return1.10%
Profit-MV
Value0.46
Score2/3
Weight15.76%
1M Return8.45%
Value0.46
Score2/3
Weight15.76%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight15.78%
1M Return8.45%
Value-0.17
Score2/3
Weight15.78%
1M Return8.45%
PB-ROE
Value0.06
Score1/3
Weight19.19%
1M Return9.57%
Value0.06
Score1/3
Weight19.19%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.65%
1M Return0.43%
Value92.66
Score2/3
Weight0.65%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight11.53%
1M Return6.68%
Value-0.50
Score1/3
Weight11.53%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight15.49%
1M Return8.41%
Value-0.07
Score2/3
Weight15.49%
1M Return8.41%
Is LBRX undervalued or overvalued?
- LBRX scores 2.86/10 on fundamentals and holds a Premium valuation at present. Backed by its -8.32% ROE, 0.00% net margin, -36.24 P/E ratio, 2.20 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.
